ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $6,958,004 | – | 1,793,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |